Every Woman Should Know Her Risk for Breast Cancer.
Now She Can with a Simple Urine Test!
When a major study of hormone replacement therapy in women was recently discontinued, clinicians and patients alike were left with unanswered questions. Why are certain tissues, such as the breast, susceptible to estrogen-induced cancer? Why are some women susceptible, but not others? Researchers at Rockefeller University have found that the body metabolizes estrogens into several different metabolites that can impact cancer development.One metabolite, 2-hydroxyestrone (2-OHE1), tends to inhibit cancer growth. Another, 16-a-hydroxyestrone (16-a-OHE1), actually encourages tumor development. A woman’s "biochemical individuality" determines which of these metabolites predominates. Studies have shown that measuring the ratio of these two metabolites provides an important indication of risk for future development of estrogen-sensitive cancers. The studies also show that this risk is modifiable! The Estronex™ 2/16 Test from Metametrix Clinical Laboratory measures the ratio of these two critical estrogen metabolites from a single urine specimen. Estronex 2/16 ratios less than 2.0 indicate increasing long-term risk for breast, cervical, and other estrogen-sensitive cancers. Importantly, nutritional interventions can help raise Estronex 2/16 ratios and decrease long-term risk.
THERMOGRAPHY
|
Digital infrared thermal imaging provides a 100% safe, painless breast screening option for women
There are many advantages when you choose DITI, they include
-
No painful compression – eliminating trauma to the breast and possible spread of any pathology that may exist
-
No harmful radiation – reducing your lifetime exposure and decreasing your risk for developing breast cancer
-
No contact - for greater comfort that supports a life long commitment to routine breast screening
-
No risks – can be done more frequently if needed for closer monitoring with no risk what so ever.
DITI’s role in breast cancer and other breast disorders is one of early detection and monitoring of abnormal physiology and the establishment of risk factors for the development or existence of cancer.
|
 |
Thermography as a physiological test, demonstrates heat patterns that are strongly indicative of breast abnormality, the test can detect subtle changes in breast temperature that
indicate a variety of breast diseases and abnormalities
There is a high degree of thermal symmetry in the normal body, subtle abnormal temperature asymmetry’s can be easily identified
|
 |
|
Any changes to her normal “thermal print” caused by early cell changes (pathology) will become increasingly apparent; DITI detects the formation of blood vessels necessary for tumors to grow (angiogensis).
For more go to South Florida Thermography
|
|
|
